One of the major symptoms of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is post-exertional malaise (PEM), the worsening of symptoms after physical or mental activities.
The Breakthrough Prize Foundation has announced that Richard J. Youle, Ph.D., a senior investigator at the National Institutes of Health (NIH), is one of four recipients of the 2021 Breakthrough Prize in Life Sciences.
When it comes to brain cells, one size does not fit all. Neurons come in a wide variety of shapes, sizes, and contain different types of brain chemicals. But how did they get that way?
The Chan Zuckerberg Initiative (CZI) has announced that a lab led by Michael E. Ward, M.D., Ph.D., investigator at the NIH’s NINDS is part of one of 30 pairs of researchers to receive an award from CZI’s Neurodegeneration Challenge Network (NDCN).
Every year, 150 to 300 children in the United States are diagnosed with diffuse intrinsic pontine gliomas (DIPGs), aggressive and lethal tumors that grow deep inside the brain, for which there are no cures.
For every cell in the body there comes a time when it must decide what it wants to do for the rest of its life. In an article published in the journal PNAS, NIH researchers report for the first time that ancient viral genes that were once considered “junk DNA” may play a role in this process.
The National Institutes of Health plans to invest $25 million over 5 years in a new program to spur innovative research on amyotrophic lateral sclerosis (ALS), a progressive and fatal neurological disease that weakens and eventually paralyzes voluntary muscles.